BioLineRx (NASDAQ:BLRX) Cut to “Sell” at StockNews.com
StockNews.com lowered shares of BioLineRx (NASDAQ:BLRX – Free Report) from a hold rating to a sell rating in a research report sent to investors on Tuesday morning. Separately, HC Wainwright dropped their target price on shares of BioLineRx from $840.00 to $360.00 and set a “buy” rating on the stock in a report on Monday, […]
StockNews.com lowered shares of BioLineRx (NASDAQ:BLRX – Free Report) from a hold rating to a sell rating in a research report sent to investors on Tuesday morning. Separately, HC Wainwright dropped their target price on shares of BioLineRx from $840.00 to $360.00 and set a “buy” rating on the stock in a report on Monday, […]
